Jiménez-Vicente C, Othman J, Potter N, Jovanovic J, Runglall M, Aucken P, Barr L, O’Sullivan J, de Lavallade H, Lim M, Harrington P, Russell N, Dillon R. Blinatumomab for measurable residual disease relapse in acute myeloid leukemia with t(8;21) translocation: the BlinAML Trial. Haematologica; https://doi.org/10.3324/haematol.2026.301120 [Early view].